American Journal of Cardiology
Volume 104, Issue 9 , Pages 1179-1183, 1 November 2009

The Chemokine Network in Relation to Infarct Size and Left Ventricular Remodeling Following Acute Myocardial Infarction

  • Stein Ørn, MD

      Affiliations

    • Division of Cardiology, Stavanger University Hospital, Stavanger, Norway
    • Institute of Internal Medicine, University of Bergen, Bergen, Norway
  • ,
  • Unni M. Breland, MD

      Affiliations

    • Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, University of Oslo, Oslo, Norway
    • Corresponding Author InformationCorresponding author: Tel: (47) 2307-3626; fax: (47) 2307-3630
  • ,
  • Tom Eirik Mollnes, MD, PhD

      Affiliations

    • Institute of Immunology, Oslo University Hospital, Rikshospitalet, University of Oslo, Oslo, Norway
  • ,
  • Cord Manhenke, MD

      Affiliations

    • Division of Cardiology, Stavanger University Hospital, Stavanger, Norway
  • ,
  • Kenneth Dickstein, MD, PhD

      Affiliations

    • Division of Cardiology, Stavanger University Hospital, Stavanger, Norway
    • Institute of Internal Medicine, University of Bergen, Bergen, Norway
  • ,
  • Pål Aukrust, MD, PhD

      Affiliations

    • Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, University of Oslo, Oslo, Norway
    • Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Rikshospitalet, University of Oslo, Oslo, Norway
  • ,
  • Thor Ueland, PhD

      Affiliations

    • Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, University of Oslo, Oslo, Norway
    • Department of Endocrinology, Oslo University Hospital, Rikshospitalet, University of Oslo, Oslo, Norway

Received 15 April 2009; received in revised form 11 June 2009; accepted 11 June 2009. published online 18 September 2009.

Increased circulating chemokines have been reported during acute myocardial infarction and might give prognostic information about future ischemic events. However, data on the chemokine network in relation to infarct size and measures of left ventricular remodeling after successful percutaneous coronary intervention (PCI) are lacking. A total of 42 patients with first-time ST-segment elevation acute myocardial infarction with a single occluded vessel were recruited, and cardiac magnetic resonance was used for serial assessment (2, 7, and 60 days) of infarct size and left ventricular remodeling. The chemokines were analyzed before and after PCI. After PCI, high levels of CCL4, CXCL16, CXCL10, and, in particular, CXCL8 within the first week after PCI correlated positively with the degree of myocardial damage, as reflected by correlations with the maximum troponin T levels and infarct size after 2 months, as assessed by cardiac magnetic resonance, and with impaired myocardial function after 2 months as assessed by cardiac magnetic resonance and neurohormonal methods. In contrast, the plasma levels of CCL3 and CXCL7 during the first week correlated negatively with myocardial dysfunction after 2 months. In conclusion, our findings suggest a role for chemokines in both adaptive and maladaptive responses after myocardial infarction and might support a role for CCL4, CXCL16, CXCL10, and, in particular, CXCL8 in postmyocardial infarction reperfusion and remodeling.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This work was supported by Helse Vest Grant 911017, Bergen, Norway; the Norwegian Association of Heart and Lung Patients, Oslo, Norway; Helse og Rehabilitering Grant 2003/2/0211, Oslo, Norway; the University of Oslo, Oslo, Norway; the Norwegian Council on Cardiovascular Disease, Oslo, Norway; and the Family Blix Foundation, Oslo, Norway.

PII: S0002-9149(09)01254-5

doi:10.1016/j.amjcard.2009.06.028

American Journal of Cardiology
Volume 104, Issue 9 , Pages 1179-1183, 1 November 2009